ArticleJournal of clinical medicine2022

Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study.

Sebastian Rauch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.